FDG-PET/CT can provide a more precise assessment of recurrence and outcome in ovarian cancer than the standard serum tumor marker. Medscape Medical News
The announcement that a trial of iniparib in breast cancer did not meet a primary endpoint prompted Dr. Kathy Miller to call for immediate disclosure of the data, the lack of which affects treatment. Medscape Hematology-Oncology
HIV-infected patients in this study were diagnosed and treated for colon adenocarcinoma and tended to have specific clinical and pathological characteristics. How should screening change? Clinical Colorectal Cancer
A multigene assay may indicate which patients with non-small cell lung cancer would benefit from adjuvant therapy, according to a study reviewed by Dr. Jack West. Medscape Hematology-Oncology
